Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).

Feature | Antiplatelet and Anticoagulation Therapies

FDA Clears First Generics for Eliquis

December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of ...

December 27, 2019

Vascepa pill contains a concentrated form of fish oil, icosapent ethyl, indication for prevention. The U.S. Food and Drug Administration (FDA) Dec. 13, 2019, approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels.

Feature | Pharmaceuticals | Dave Fornell, Editor

FDA Expands Vascepa to Reduce Cardiovascular Events in Elevated Triglyceride Patients

December 16, 2019 — The U.S. Food and Drug Administration (FDA), on Dec. 13, approved the use of Vascepa (icosapent ...

December 16, 2019

News | Antiplatelet and Anticoagulation Therapies

Low-dose Aspirin May Not Help African Americans Prevent Heart Disease

December 12, 2019 — Low-dose aspirin was not associated with a reduced risk of a fatal heart attack among African ...

December 12, 2019

News | Cardiovascular Clinical Studies

Virtual Study to Track Statin-Related Adverse Events Being Undertaken by University of Connecticut and Hartford Healthcare

November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have ...

November 26, 2019

Heart failure VICTORIA TrIal a success. Dave Fornell

News | Heart Failure

Investigational Drug Vericiguat Reduced the Risk of Heart Failure Hospitalization in VICTORIA Trial

November 21, 2019 — Merck announced the results from the Phase 3 VICTORIA Study evaluating the efficacy and safety of ...

November 21, 2019

In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff

Feature | AHA

ISCHEMIA Trial Results Find Interventions for Stable Heart Disease No better Than Drug Therapy

November 19, 2019 — After 12 years of collecting data, the results of the landmark ISCHEMIA (International Study of ...

November 19, 2019

Feature | AHA | Dave Fornell, Editor

American Heart Association 2019 Late-breaking Trials

November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at the ...

November 19, 2019

Cholesterol test prep blood draw needle stick from American Heart Association

News | AHA

ASCVD Patients Face Barriers Reaching Guideline-Recommended Cholesterol Goals

November 14, 2019 — A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the NCDR ...

November 14, 2019

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

News

Cleveland Clinic Unveils Top 10 Medical Innovations for 2020

November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last ...

November 06, 2019

EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment for structural heart procedures. #TCT2019 #TCT #TCT19

Feature | TCT | Dave Fornell, Editor

6 Hot Topics in Interventional Cardiology at TCT 2019

The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual Transca ...

November 04, 2019

Former National Football League (NFL) player Ed White (left) needed a new aortic heart valve but decided to wait several months for the FDA to approve TACR for low-risk patients so he would not have to undergo open heart surgery. Democratic presidential candidate Sen. Bernie Sanders received two stents after he was hospitalized with chest pain was hospitalized with chest pain on Oct. 1 in Las Vegas. The event brought PCI to the forefront of national news in October.

Feature | Dave Fornell, Editor

November 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

November 01, 2019

The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's dapagliflozin (Farxiga) to reduce the risk of hospitalization for heart failure (HF) in adults with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.

Feature | Heart Failure | Dave Fornell, Editor

FDA Clears Dapagliflozin to Reduce Heart Failure Hospitalizations

October 21, 2019 – The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's ...

October 21, 2019

Videos | Antiplatelet and Anticoagulation Therapies

VIDEO: New PLATINUM Diversity Data Shows Early DAPT Cessation OK in Minorities With New Generation Stent

Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...

October 17, 2019

News | Heart Failure

Research Shows Drug Can Extend Survival Rates for Heart Failure Patients

October 16, 2019 — Researchers have shown for the first time in preclinical studies that the drug Aliskiren can delay ...

October 16, 2019

Videos | Antiplatelet and Anticoagulation Therapies

VIDEO: Early Discontinuation of DAPT in High Bleeding Risk Patients With the Synergy Stent

Ajay J. Kirtane, M.D., associate professor of medicine at Columbia University Irving Medical Center and director of the ...

October 11, 2019